This review sought to systematize knowledge about the use of artificial intelligence in neurobiological research of mental disorders and assess its potential in identifying their causes.
Methods
A qualitative synthesis of scientific literature from the Scopus and Web of Science databases for 2020-2024 was conducted. A total of 50 sources were selected, including papers describing the use of artificial intelligence in the analysis of neuroimaging, biomarkers, cognitive impairment, and genetic data. A thematic encoding was used to analyse methods, accuracy, and limitations.
Results
Machine learning algorithms have accelerated the processing of large amounts of data, including magnetic resonance imaging, electroencephalogram, and genomic profiles, which has revealed new biomarkers and neural patterns associated with depression and schizophrenia. However, artificial intelligence technologies face several limitations: low specificity, high computational complexity, and problems with reproducibility of results.
Conclusions
The integration of artificial intelligence with neuroscience has significantly advanced the understanding of the aetiology of mental disorders, revealing the complex relationships between genetic, neural, and behavioural factors. The practical significance of the research lies in the potential of artificial intelligence to create personalised approaches to the diagnosis and treatment of mental disorders. This can improve the quality of life of patients and reduce the burden on healthcare systems.
BiróACuesta-VargasAISzilágyiL. Precognition of mental health and neurogenerative disorders using AI-parsed text and sentiment analysis. Acta Univ Sapientiae, Inf. 2023;15(2):359-403. doi:10.2478/ausi-2023-0022.
3.
KerzEZanwarSQiaoYWiechmannD. Toward explainable AI (XAI) for mental health detection based on language behavior. Front Psychiatry. 2023;14:1219479. doi:10.3389/fpsyt.2023.1219479.
4.
HassantabarSZhangJYinHJhaNK. MHDeep: mental health disorder detection system based on wearable sensors and artificial neural networks. ACM Trans Embed Comput Syst. 2022;21(6):81. doi:10.1145/3527170.
5.
RoyAAcharyaABiswasS, et al.Identification and classification of human mental stress using physiological data: a low-power hybrid approach. In: 2022 IEEE 6th International Conference on Condition Assessment Techniques in Electrical Systems. Durgapur. IEEE; 2022:136-139. doi:10.1109/CATCON56237.2022.10077709.
6.
VegesnaVV. AI-powered mental health monitoring using wearable devices and mobile sensing. Int Res J Comput Sci. 2024;11(8):545-550.
7.
DhimanVK. The emergence of AI in mental health: a transformative journey. World J Adv Res Rev. 2024;22(1):1867-1871. doi:10.30574/wjarr.2024.22.1.1298.
8.
RamírezLÁ. Artificial intelligence in psychological diagnosis and intervention. LatIA. 2024;1:26. doi:10.62486/latia202326.
9.
LiYZengWDengJ, et al.Exploring dysconnectivity of the large-scale neurocognitive network across psychiatric disorders using spatiotemporal constrained nonnegative matrix factorization method. Cereb Cortex. 2022;32(20):4576-4591. doi:10.1093/cercor/bhab503.
10.
XiaoJWuJ. Effectiveness of the neuroimaging techniques in the recognition of psychiatric disorders: a systematic review and meta-analysis of RCTs. Curr Med Imaging. 2023;20:e260523217379. doi:10.2174/1573405620666230526113304.
11.
HoyNLynchSWaszczukMReppermundSMewtonL. Investigating the molecular genetic, genomic, brain structural, and brain functional correlates of latent transdiagnostic dimensions of psychopathology across the lifespan: protocol for a systematic review and meta-analysis of cross-sectional and longitudinal studies in the general population. Front Psychiatry. 2022;13:1036794. doi:10.3389/fpsyt.2022.1036794.
12.
DzialasVDoeringEEichH, et al.Houston, we have AI problem! quality issues with neuroimaging-based artificial intelligence in Parkinson's disease: a systematic review. Mov Disord. 2024;39(12):2130-2143. doi:10.1002/mds.30002.
13.
SamiotisAHicksAJPonsfordJSpitzG. Transdiagnostic MRI markers of psychopathology following traumatic brain injury: a systematic review and network meta-analysis protocol. BMJ Open. 2023;13(9):e072075. doi:10.1136/bmjopen-2023-072075.
14.
RajanSSchwarzE. Network-based artificial intelligence approaches for advancing personalized psychiatry. Am J Med Genet B Neuropsychiatr Genet. 2024;195(8):e32997. doi:10.1002/ajmg.b.32997.
15.
EsagoffAStevensDBrayM, et al.Neuroimaging correlates of post-traumatic stress disorder in traumatic brain injury: a systematic review of the literature. Eur Psychiatry. 2022;65(1):471-472. doi:10.1192/j.eurpsy.2022.1198.
16.
AgarwalSWoodDGrzedaM, et al.Systematic review of artificial intelligence for abnormality detection in high-volume neuroimaging and subgroup meta-analysis for intracranial hemorrhage detection. Clin Neuroradiol. 2023;33(4):943-956. doi:10.1007/s00062-023-01291-1.
17.
LariosELernerI. Habitual rapid eye movement sleep predicts changes in test-anxiety levels weeks in advance. J Sleep Res. 2025;34(1):e14298. doi:10.1111/jsr.14298.
18.
McGenityCClarkeELJenningsC, et al.Artificial intelligence in digital pathology: a systematic review and meta-analysis of diagnostic test accuracy. npj Digit Med. 2024;7:114. doi:10.1038/s41746-024-01106-8.
19.
EnnabMMcheickH. Enhancing interpretability and accuracy of AI models in healthcare: a comprehensive review on challenges and future directions. Front Robot AI. 2024;11:1444763. doi:10.3389/frobt.2024.1444763.
20.
OmiyefaS. Artificial intelligence and machine learning in precision mental health diagnostics and predictive treatment models. Int J Res Publ Rev. 2025;6(3):85-99. doi:10.55248/gengpi.6.0325.1107.
21.
BaydiliİTasciBTasciG. Artificial intelligence in psychiatry: a review of biological and behavioral data analyses. Diagnostics. 2025;15(4):434. doi:10.3390/diagnostics15040434.
22.
RamezaniRIranmaneshSNaeimABenharashP. Bench to bedside: AI and remote patient monitoring. Front Digit Health. 2025;7:1584443. doi:10.3389/fdgth.2025.1584443.
23.
JiangSJiaQPengZ, et al.Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia?Schizophrenia. 2025;11:32. doi:10.1038/s41537-025-00583-4.
24.
ShiJZhouZDuXCavagnaroMJCaiJ. Editorial: new insights and perspectives on traumatic brain injury: integration, translation and multidisciplinary approaches. Front Neurol. 2024;15:1427320. doi:10.3389/fneur.2024.1427320.
25.
CarpentieriVLambacherGTroianielloM, et al.Methylation dynamics on 5′-UTR of DAT1 gene as a bio-marker to recognize therapy success in ADHD children. Children. 2023;10(3):584. doi:10.3390/children10030584.
26.
CoffmanBATorrenceNMurphyT, et al.Trait sensation seeking is associated with heightened beta-band oscillatory dynamics over left ventrolateral prefrontal cortex during reward expectancy. J Affect Disord. 2021;292:67-74. doi:10.1016/j.jad.2021.05.029.
27.
MazurMKrukowP. The significance of natural language processing and machine learning in schizophasia description: identification of research trends and perspectives in schizophrenia language studies. Curr Probl Psychiatry. 2024;25:127-135. doi:10.12923/2353-8627/2024-0013.
28.
ObuchiSPKojimaMSuzukiH, et al.Artificial intelligence detection of cognitive impairment in older adults during walking. Alzheimers Dement (Amst). 2024;16(3):e0012. doi:10.1002/dad2.70012.
29.
AghaeiMVahabiZModarresMHEbrahiminiaFKhaligh-RazaviSM. Association between a computerized, self-administered cognitive assessment and phosphorylated Tau in Alzheimer’s disease. 2024;1-15. doi:10.1101/2024.11.23.24317846
30.
TanWYHargreavesCChenCHilalS. A machine learning approach for early diagnosis of cognitive impairment using population-based data. J Alzheimers Dis. 2022;91(1):449-461. doi:10.3233/JAD-220776.
31.
LiuHZhangXLiuHChongST. Using machine learning to predict cognitive impairment among middle-aged and older Chinese: a longitudinal study. Int J Public Health. 2023;68:1605322. doi:10.3389/ijph.2023.1605322.
32.
JungWKimSEKimJP, et al.Deep learning model for individualized trajectory prediction of clinical outcomes in mild cognitive impairment. Front Aging Neurosci. 2024;16:1356745. doi:10.3389/fnagi.2024.1356745.
33.
LinFHanJXueT, et al.Predicting cognitive impairment in outpatients with epilepsy using machine learning techniques. Sci Rep. 2021;11:20002. doi:10.1038/s41598-021-99506-3.
34.
HuMShuXYuGWuXVälimäkiMFengH. A risk prediction model based on machine learning for cognitive impairment among Chinese community-dwelling elderly people with normal cognition: development and validation study. J Med Internet Res. 2021;23(2):e20298. doi:10.2196/20298.
35.
JiangJWangMAlbertsI, et al.Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2022;49:2163-2173. doi:10.1007/s00259-022-05687-y.
36.
LotterLDKohlSHGerloffC, et al.Revealing the neurobiology underlying interpersonal neural synchronization with multimodal data fusion. Neurosci Biobehav Rev. 2023;146:105042. doi:10.1016/j.neubiorev.2023.105042.
37.
LeonardsenEHVidal-PiñeiroDRoeJM, et al.Genetic architecture of brain age and its causal relations with brain and mental disorders. Mol Psychiatry. 2023;28:3111-3120. doi:10.1038/s41380-023-02087-y.
38.
HuangY-JChenC-HYangH-C. AI-enhanced integration of genetic and medical imaging data for risk assessment of type 2 diabetes. Nat Commun. 2024;15:4230. doi:10.1038/s41467-024-48618-1.
39.
RamananVKGebreRKGraff-RadfordJ, et al.Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis. Brain. 2023;146(11):4508-4519. doi:10.1093/brain/awad196.
40.
van der EsTSoheili-NezhadSMotaN, et al.Exploring the genetic architecture of brain structure and ADHD using polygenic neuroimaging-derived scores. Am J Med Genet B Neuropsychiatr Genet. 2024;198(1):e32987. doi:10.1002/ajmg.b.32987.
41.
SkampardoniINasrallahIMAbdulkadirA, et al.Genetic and clinical correlates of AI-based brain aging patterns in cognitively unimpaired individuals. JAMA Psychiatry. 2024;81(5):456-467. doi:10.1001/jamapsychiatry.2023.5599.
42.
TaoZYangWZhuW, et al.A neural-related gene risk score for head and neck squamous cell carcinoma. Oral Dis. 2024;30(2):477-491. doi:10.1111/odi.14434.
43.
WorthenATorousJKhanSHammesNRabinowitzT. Telepsychiatry current practice and implications for future trends: a 2023 American Psychiatric Association member survey. Telemed J e Health. 2024;30(11):2662-2668. doi:10.1089/tmj.2024.0042.
44.
RokhamHFalakshahiHFuZPearlsonGCalhounVD. Evaluation of boundaries between mood and psychosis disorder using dynamic functional network connectivity (dFNC) via deep learning classification. Hum Brain Mapp. 2023;44(8):3180-3195. doi:10.1002/hbm.26273.
45.
WuHZhouYWangY, et al.Current state and future directions of intranasal delivery route for central nervous system disorders: a scientometric and visualization analysis. Front Pharmacol. 2021;12:717192. doi:10.3389/fphar.2021.717192.
46.
IftimoviciAKrebsEDalfinW, et al.Neurodevelopmental predictors of treatment response in schizophrenia and bipolar disorder. Psychol Med. 2024;54(13):3655-3666. doi:10.1017/S0033291724001776.
47.
PatelRWeeSNRamaswamyR, et al.NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data. BMJ Open. 2022;12(4):e057227. doi:10.1136/bmjopen-2021-057227.
48.
KeaneBPAbrhamYTHearneLJBiHHuB. Increased whole-brain functional heterogeneity in psychosis during rest and task. Neuroimage Clin. 2024;43:103630. doi:10.1016/j.nicl.2024.103630.
49.
VeldmeijerLTerlouwGvan OsJTe MeermanSvan 't VeerJBoonstraN. From diagnosis to dialogue - reconsidering the DSM as a conversation piece in mental health care: a hypothesis and theory. Front Psychiatry. 2024;15:1426475. doi:10.3389/fpsyt.2024.1426475.
50.
MilasanLHScott‐PurdyD. The future of artificial intelligence in mental health nursing practice: an integrative review. Int J Ment Health Nurs. 2025;34(1):e70003. doi:10.1111/inm.70003.
